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Abstract
Volume and change in volume of the hippocampus are both important markers of Alzheimer's disease
(AD). Delineation of the structure on MRI is time-consuming and therefore reliable automated
methods are required. We describe an improvement (multiple-atlas propagation and segmentation
(MAPS)) to our template library-based segmentation technique. The improved technique uses non-
linear registration of the best-matched templates from our manually-segmented library to generate
multiple segmentations and combines them using the simultaneous truth and performance level
estimation (STAPLE) algorithm. Change in volume over 12 months (MAPS-HBSI) was measured
by applying the boundary shift integral using MAPS regions. Methods were developed and validated
against manual measures using subsets from Alzheimer's Disease Neuroimaging Initiative (ADNI).
The best method was applied to 682 ADNI subjects, at baseline and 12-month follow-up, enabling
assessment of volumes and atrophy rates in control, mild cognitive impairment (MCI) and AD groups,
and within MCI subgroups classified by subsequent clinical outcome. We compared our measures
with those generated by SNT (Surgical Navigation Technologies) available from ADNI. The
accuracy of our volumes was one of the highest reported (mean(SD) Jaccard Index 0.80(0.04)
(N=30)). Both MAPS baseline volume and MAPS-HBSI atrophy rate distinguished between control,
MCI and AD groups. Comparing MCI subgroups (reverters, stable and converters): volumes were
lower and rates higher in converters compared with stable and reverter groups (p≤0.03). MAPS-HBSI
required the lowest sample sizes (68 subjects) for a hypothetical trial. In conclusion, the MAPS and
MAPS-HBSI methods give accurate and reliable volumes and atrophy rates across the clinical
spectrum from healthy aging to AD.
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Introduction
A diagnosis of Alzheimer's disease (AD), the most common cause of dementia, can only be
confirmed pathologically by the presence of intracellular neurofibrillary tangles made of tau
protein and extracellular amyloid plaques. The hippocampus is affected early in the disease
(Braak and Braak, 1991) and hippocampal atrophy using magnetic resonance imaging (MRI)
has been shown to be a marker of AD pathology (Likeman et al., 2005). Hippocampal atrophy
is also predictive of clinical decline at a mild cognitive impairment (MCI) stage (Henneman
et al., 2009; Jack et al., 1999) and even presymptomatically in familial AD (Fox et al., 1996;
Ridha et al., 2006). As a result, reduced hippocampal volume using MRI has recently been
proposed as part of new criteria to allow a diagnosis of AD to be made earlier than would be
possible on purely clinical grounds (Dubois et al., 2007).
Not only is there interest in single time-point assessment of hippocampal integrity using
structural imaging, but there is also interest in measuring volume change over time.
Significantly increased hippocampal atrophy rates have been shown by many studies in
subjects with AD (Barnes et al., 2008b; Henneman et al., 2009; Jack et al., 2000; Jack et al.,
2004; Thompson et al., 2004) and MCI (Henneman et al., 2009; Jack, Jr. et al., 2005; Schuff
et al., 2009) compared with control subjects of a similar age. Atrophy rates have been shown
to increase gradually early in the course of both familial (Ridha et al., 2006) and sporadic AD
(Jack, Jr. et al., 2008b) and to be predictive of future decline from MCI to AD (Henneman et
al., 2009). Hippocampal rates of atrophy have been used to assess putative disease-modifying
treatments for AD (Fox et al., 2005; Hashimoto et al., 2005; Jack et al., 2003).
However, the hippocampus is a complex anatomical structure and manual segmentation, even
with some degree of computer assistance, requires around 45 minutes per hippocampus by
trained raters in order to achieve reasonable reproducibility (e.g. less than 5% of difference in
volume both within and between raters) (Fox et al., 1996). Consequently, many attempts have
been made to automate or reduce manual involvement in the segmentation process. These
techniques include using deformable models (Ashton et al., 1997; Chupin et al., 2009b;
Duchesne et al., 2002; Kelemen et al., 1999; Patenaude et al., 2007; Pitiot et al., 2004; Shen et
al., 2002) or voxel classification (Fischl et al., 2002; Gosche et al., 2001). These techniques
are usually combined with anatomical and probabilistic priors to aid segmentations. Most of
the deformable model techniques are based on statistical shape models to constrain label
generation (Duchesne et al., 2002; Kelemen et al., 1999; Patenaude et al., 2007; Shen et al.,
2002) whereas others employ anatomical priors and competitive deformation of neighbouring
structures to segment the structure (Ashton et al., 1997; Chupin et al., 2009b). Other techniques
utilize some form of registration and region propagation with most using nonlinear (Aljabar et
al., 2009; Carmichael et al., 2005; Collins et al., 1996; Schuff et al., 2009) rather than linear
(Barnes et al., 2008a; Webb et al., 1999) registration. A hybrid technique combining the voxel
classification and region propagation was also proposed and shown to improve the results from
either method (Collins et al., 1999).
Techniques which utilise atlases or templates vary between making a probabilistic atlas from
a set of images (Hammers et al., 2003; Shattuck et al., 2008) to using a single subject template
(Haller et al., 1997). The main drawback with the use of single subject templates is that they
cannot encompass the very wide inter-individual variability (Figure 1) which will be present
within the study. This can be partially circumvented by deforming the individual template to
the average shape of all images in the study (Kochunov et al., 2002), but no single template
could be adequately warped to all potential anatomical variations. Average templates or atlases
built from multiple subjects include the necessary variability but do not necessarily preserve
the anatomical resolution required for small structures such as the hippocampus. Using an
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average of all labelled subjects also typically means that individual subjects in the study will
be poorly matched (in terms of anatomy and/or acquisition properties) to some subjects. By
selecting one or more templates from a library of labelled images (multi-atlas selection or
fusion) (Aljabar et al., 2009; Barnes et al., 2008a; Klein et al., 2008) it is possible to include
variability without loss of resolution or quality of matching. The disease status of subjects used
in the atlas system or training dataset may affect results obtained on a different dataset; most
studies have atlas systems based on normal controls (Fischl et al., 2002; Hammers et al.,
2002; Hammers et al., 2007; van der Lijn et al., 2008; Webb et al., 1999) while few include
both normal and specific patient groups (Barnes et al., 2008a). Furthermore, a recent
publication by Wolz et al. (2010) addressed this problem by propagating the initial set of atlases
of normal controls to all images in the dataset (containing normal controls, MCI and AD
subjects) through a succession of multi-atlas segmentation steps – effectively breaking down
the problem of registering “dissimilar” images into a problem of registering a series of relatively
“similar” images (Wolz et al., 2010).
Very few fully-automated systems of measuring hippocampal change have been generated:
most have some level of intervention from manually segmenting baseline hippocampi and
using fluid registration (Crum et al., 2001) or linear registration combined with boundary shift
integral (BSI) (Barnes et al., 2004) to measure change directly within the region. Other methods
include application of the cross-sectional technique to baseline and repeat images separately
to measure change indirectly (Schuff et al., 2009; Wang et al., 2003).
In our previously published multi-atlas single-site study we described a leave-one-out
experiment where for each individual we found the best match from all other subjects in the
study based on the similarity of images in the hippocampal area (Barnes et al., 2008a). This
best match was then used as a single-person template together with linear registration,
morphological operations and intensity thresholding. This technique was able to generate
single time-point hippocampal regions of sufficient accuracy to generate relative rates of
atrophy using serial images. In this study, we select top matches from our multi-atlas system
to generate multiple segmentations (Aljabar et al., 2009) and combine them using label fusion
methods (Heckemann et al., 2006; Rohlfing and Maurer, Jr., 2007; Warfield et al., 2004). For
brevity, we refer to the technique as multiple-atlas propagation and segmentation (MAPS). We
evaluate MAPS on multi-site data of over 680 subjects with serial volumetric MRI from the
Alzheimer's Disease Neuroimaging Initiative (ADNI, http://www.loni.ucla.edu/ADNI/). Our
aim was first to determine the ability of MAPS to distinguish between normal controls, MCI
and AD subjects; and between subgroups of subjects diagnosed as MCI at baseline that were
subsequently diagnosed as normal (“reverters”), MCI (“stable”) or AD (“converters”). We also
wished to assess its ability to track change in the hippocampus in controls, MCI and AD
subjects, and to estimate sample sizes that would be needed in a putative disease-modifying
clinical trial.
Methods
Overview
We first trained the segmentation algorithm on the left hippocampi of a subset of 15 manually
labelled images, to optimise the various methodological options and parameters. Segmentation
accuracy was then directly measured on the left hippocampi of an independent test set of 30
further manually labelled images. We then indirectly evaluated performance on a much larger
set of 682 (unlabelled) images, using metrics such as sample size for a hypothetical clinical
trial. We finally compared directly estimated MAPS-HBSI atrophy rates to indirect rates from
differences in volumes from applying MAPS to the two time-points.
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Image data
We downloaded pre-processed baseline and 12-month repeat volumetric T1-weighted MR
scans acquired using 1.5T scanners (General Electric Healthcare, Philips Medical Systems or
Siemens Medical Solutions) at multiple sites from the ADNI website. Representative imaging
parameters were TR = 2400ms, TI = 1000ms, TE = 3.5ms, flip angle = 8°, field of view = 240
× 240mm and 160 sagittal 1.2mm-thick-slices and a 192 × 192 matrix yielding a voxel
resolution of 1.25 × 1.25 × 1.2 mm3, or 180 sagittal 1.2mm-thick-slices with a 256 × 256 matrix
yielding a voxel resolution of 0.94 × 0.94 × 1.2 mm3. The details of the ADNI MR imaging
protocol are described in (Jack, Jr. et al., 2008a), and listed on the ADNI website
(http://www.loni.ucla.edu/ADNI/Research/Cores/). The T1-weighted volumetric scans that
were designated to be the “best” after quality control were processed using the standard ADNI
image processing pipeline, which included post-acquisition correction of gradient warping
(Jovicich et al., 2006), B1 non-uniformity correction (Narayana et al., 1998) depending on the
scanner and coil type, intensity non-uniformity correction (Sled et al., 1998) and phantom based
scaling correction (Gunter et al., 2006) - the geometric phantom scan having been acquired
with each patient scan.
Clinical and demographic data are shown in Tables 1-4. Table 1 shows the demographic data
of the 15 randomly-selected subjects (5 control, 5 MCI and 5 AD) used for method optimisation.
Table 2 shows the demographic data of the 30 randomly-selected subjects (10 control, 10 MCI
and 10 AD) used for method validation (note that this subset of 30 subjects was separate from
the subset of 15 subjects used for method optimisation). Table 3 shows the demographic data
of 682 subjects (200 control, 335 MCI and 147 AD) in our full dataset. We also sub-divided
the MCI subjects into three subgroups (8 reverters, 204 stable and 123 converters) based on
their follow-up clinical diagnoses determined up to 36 months after baseline. Table 4 shows
the demographic data of the MCI subgroups.
ADNI was launched in 2003 by the National Institute on Aging (NIA), the National Institute
of Biomedical Imaging and Bioengineering (NIBIB), the Food and Drug Administration
(FDA), private pharmaceutical companies and non-profit organizations, as a 5-year public-
private partnership. The aims of ADNI included assessing the ability of imaging and other
biomarkers to measure the progression of mild cognitive impairment (MCI) and early
Alzheimer's disease (AD).
The Principal Investigator of this initiative is Michael W. Weiner, M.D., VA Medical Center
and University of California - San Francisco. ADNI is the result of efforts of many co-
investigators from a broad range of academic institutions and private corporations, and subjects
have been recruited from over 50 sites across the U.S. and Canada. The initial goal of ADNI
was to recruit 800 adults, ages 55 to 90, to participate in the research -- approximately 200
cognitively normal older individuals, 400 people with MCI, and 200 people with early AD.
For up-to-date information see www.adni-info.org.
Template library creation
We used a previously-described hippocampal template library of manually-segmented regions
from 55 subjects scanned at a single site 1.5T GE scanner using a volumetric T1-weighted
acquisition (Barnes et al., 2008a). The left and right hippocampal regions were manually
segmented by an expert segmentor S1. A detailed description of the template library creation
is included in the Appendix.
Method optimisation using a manually-segmented subset of 15 subjects
Based on the same manual segmentation protocol as in the template library creation, the expert
segmentor S1 manually delineated the left hippocampus on the baseline and repeat T1-
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weighted MR images of 15 randomly-selected subjects (5 AD, 5 MCI, 5 controls; details in
Table 1) from the ADNI dataset, in order to assess which methods and parameters provided
the most accurate and reliable segmentation using the baseline left hippocampi (cross-sectional
analysis). In the longitudinal analysis, we assessed any differences between automated
longitudinal changes in volume calculated by the boundary shift integral (BSI) (Freeborough
and Fox, 1997) using automated baseline regions and two measures of changes: i) BSI using
manual baseline regions and ii) manual rates of atrophy derived from the volume difference
of manual segmentations at both time-points. Furthermore, we assessed separately, in both
baseline and repeat images, the intra-rater and inter-rater variability of manual hippocampal
segmentation in 15 subjects.
Cross-sectional analysis—Each subject's baseline scan and its flipped mirror image
(along the mid-sagittal plane) were registered to the control to which all the template library
scans were registered (12 dof brain to brain followed by 6 dof hippocampus to hippocampus).
This flipping effectively doubled the size of the template library by allowing, for example, the
left hippocampus in the ADNI subject to be matched to the right hippocampus in the template
library. Best matches for each hippocampus were ranked as to their similarity over the
corresponding dilated hippocampal regions using the cross-correlation (R2) between the ADNI
subject images (flipped and unflipped) and the template library. Cross correlation has been
shown to provide a good criterion for template selection in the hippocampal region in multi-
centre imaging data (Aljabar et al., 2009). Once a rank of best to worst matches for each
hippocampus was established, a subset of the highest ranking matchers could be used to
propagate the undilated hippocampal regions onto the subset of images to be segmented.
The process of optimising the method and parameters for the automated hippocampal
segmentation is depicted in Figure 2. At each stage we found the method and parameters which
produced the most accurate region as compared with the manual region determined by the
mean Jaccard index (JI) (Jaccard, 1907), which was defined as JI(A, B) = | A ∩ B | / | A ∪ B
|, where A is the set of voxels in the automated region and B is the set of voxels in the manual
region. We began by assessing the registration algorithm and compared linear 12 dof
registration (Woods et al., 1998a) with non-linear registration based on free form deformation
(FFD) (Rueckert et al., 1999), in which multiple control point spacings (16mm→8mm→4mm)
were used in order to model increasingly local deformations. Since intensity thresholds were
used in the semi-automated hippocampal segmentation to exclude white matter and CSF
(Barnes et al., 2008a), the regions from the better registration algorithm were identically
thresholded to assess if this improved the segmentation accuracy. We then compared the
combination of segmentations from the top 4 to the top 30 matches using the “vote
rule” (Heckemann et al., 2006), simultaneous truth and performance level estimation
(STAPLE) (Warfield et al., 2004) and shape-based average (SBA) (Rohlfing and Maurer, Jr.,
2007) to determine the optimal number of matches. Furthermore, we assessed whether the use
of a Markov random field (MRF) model in STAPLE to incorporate spatial smoothness would
further improve the segmentation accuracy. We tested the interaction strength parameter
between neighbouring voxels from 0 to 0.5 using increments of 0.1. Note that we followed
Heckemann et al. (2006) and only used odd numbers of segmentations in the “vote rule”.
Longitudinal analysis—Using the most accurate baseline hippocampal region, we then
assessed whether using local registration (Woods et al., 1998a) of serial hippocampi combined
with BSI (Freeborough and Fox, 1997) produced reasonable change in volume measures in the
subset. Hippocampal BSI (HBSI) was calculated using a double intensity window approach
(Hobbs et al., 2009) (see Appendix for details), in order to capture changes across both the
CSF-hippocampal border and the white matter-hippocampal border. Since the images were
acquired from different scanner manufacturers and models in ADNI, we computed the intensity
windows for the CSF-hippocampal border and the white matter-hippocampal border for each
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image pair, and used them to compute HBSI of that image pair. We referred to this method of
assessing longitudinal change in hippocampal volume using MAPS and HBSI as MAPS-HBSI.
We compared MAPS-HBSI against a HBSI generated using the manual baseline region
(manualHBSI), and a completely manual atrophy rate (difference of manual hippocampal
volumes at baseline and repeat) in the subset of 15 subjects using only the left hippocampus.
Intra-rater variability of manual hippocampal segmentation—The same baseline and
repeat images from the 15 subjects were segmented manually again by the same expert
segmentor S1 following an interval of more than two months to allow assessment of manual
intra-rater reliability in both volumes and change in volumes. To assess reliability of the HBSI
measure, a second manualHBSI was calculated using the second manually-segmented baseline
region.
Inter-rater variability of manual hippocampal segmentation—Based on the manual
segmentation protocol in the template library creation, another expert segmentor S2 manually
delineated the left hippocampus on the same baseline and repeat images from the 15 subjects,
in order to assess manual inter-rater reliability in both volumes and change in volumes.
Statistical methods—All analyses were performed using STATA (version 10). To examine
whether the average magnitude and variability of rates differed between the manual and
automated methods, we calculated the differences in mean and ratios of standard deviation
(SD) of volumes and atrophy rates between manual and automated measurements, according
to subject group. Confidence intervals were found for the mean differences assuming normality
of the paired differences, and for the ratio of SDs using Pitman's method (Pitman, 1939).
To assess intra-rater reliability, intra-class correlations (ICCs) and JIs for pairs of manually-
segmented volumes delineated by the expert segmentor S1 were calculated, ignoring subject
group, at baseline and repeat. In addition an intra-rater ICC was calculated for the difference
in volumes over time generated from the first segmentation of the 15 pairs delineated by S1
compared with the difference in volumes over time generated from the second segmentation
of the 15 pairs delineated by S1. Similarly an intra-rater ICC was calculated for the two HBSIs
generated from the first and second baseline mask delineated by S1. Confidence intervals were
found using the iccconf command in STATA.
To assess inter-rater reliability, intra-class correlations (ICCs) and JIs for pairs of manually-
segmented volumes delineated by the expert segmentors S1 and S2 were calculated, ignoring
subject group, at baseline and repeat. An inter-rater ICC was calculated for the difference in
volumes over time generated from the first segmentation of the 15 pairs delineated by S1
compared with the difference in volumes over time generated from the second segmentation
of the 15 pairs delineated by S2. Similarly an inter-rater ICC was calculated for the two HBSIs
generated from the baseline masks delineated by S1 and S2. Inter-rater ICCs and 95%
confidence intervals were found using the icc23 command in STATA, assuming random rater
effects.
Method validation using a manually-segmented subset of 30 subjects
For the method validation, the expert segmentor S1 manually delineated the left hippocampus
in the baseline images of another subset of 30 randomly selected subjects in the ADNI database
(10 AD, 10 MCI and 10 controls; details in Table 2) that differed from the subset of 15 subjects
used for the method optimisation. We applied the optimised methods and parameters as
determined above to generate left hippocampal regions in the baseline images for this subset,
in order to assess any differences between manual and automated hippocampal regions.
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Statistical methods—To examine whether the average magnitude and variability differed
between the manual and automated methods, we calculated the differences in mean and ratios
of standard deviation (SD) of volumes between manual and automated measurements,
according to subject group. Confidence intervals were found for the mean differences assuming
normality of the paired differences, and for the ratio of SDs using Pitman's method.
Analysis of the full dataset
We used the optimised methods and parameters as determined above to generate baseline and
repeat hippocampal volume from MAPS and rate of change from MAPS-HBSI for each subject
in our full dataset (detailed in Table 3 and 4). All baseline hippocampal regions were visually
checked for large segmentation errors by the expert segmentor S1. We assessed volumes and
changes in subjects by baseline diagnosis (controls, MCI and AD), and by the MCI subgroups
(reverters, stable and converters).
We generated a head size measure by estimating total intracranial volume (TIV) from the
summation of the volumes of grey matter (GM), white matter (WM) and CSF. Each of these
volumes was computed by summing (over voxels) the values of probabilistic tissue
segmentations produced using the new segmentation toolbox available in SPM8
(http://www.fil.ion.ucl.ac.uk/spm/software/spm8), multiplied by the voxel volume in ml.
SPM8's new segmentation is an extension of the unified segmentation model (Ashburner and
Friston, 2005); importantly, for the purpose of TIV estimation, one of the extensions is the use
of tissue (prior) probability maps (TPMs) for non-brain tissue. The version used here (SPM8
rev.3164) has six TPMs: GM, WM, CSF, bone, non-brain soft-tissue, and air. The additional
TPMs improve the segmentation of CSF, in contrast to earlier versions of SPM, where this has
been observed to be a problem (Shuter et al., 2008).3
Hippocampal volumes at baseline and 12 months as calculated by using a non-linear warping
technique from a template aided by the placement of manual landmarks (Haller et al., 1997)
were downloaded from the ADNI website4. The technique (referred to as SNT) is commercially
available from Medtronic Surgical Navigation Technologies (Louisville, CO) and has been
validated in elderly subjects including MCI and AD patients (Hsu et al., 2002), and results
using ADNI data have been reported recently (Schuff et al., 2009). Annualised hippocampal
atrophy rates calculated by normalising the difference between baseline and 12-month
hippocampal volumes by the baseline hippocampal volume and scan interval were referred to
as indirect atrophy rates. We compared MAPS to SNT in terms of volumes, indirect atrophy
rates, correlations with cognitive scores, and sample size estimates. Finally, we compared the
indirect and direct methods of estimating atrophy rates using the automated regions from
MAPS, namely MAPS indirect atrophy rate (calculated from the baseline and 12-month
hippocampal volumes) and MAPS-HBSI (calculated from the boundary shift integral), in terms
of atrophy rates, correlations with cognitive scores and sample size estimates.
Statistical methods—Again, all analyses were performed using STATA (version 10). To
examine differences between groups in baseline volume, we fitted a linear regression model,
using age, gender, and TIV as covariates in the regression model. We estimated between-group
differences in atrophy rates using a similar linear regression model, with adjustment for age
and gender. We fitted regression models using data only from MCI subjects to investigate
differences across MCI subgroups according to follow-up diagnosis (reverters, stable and
3TIV estimation will be evaluated in greater detail elsewhere, but in brief, using 67 subjects with manually derived TIV (according to
the protocol of (Whitwell et al., 2001) values from SPM8's new segmentation toolbox had a correlation of 0.989, which exceeded values
from SPM5 and SPM2.
4Downloaded on 17th September 2009.
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converters), for both volumes and atrophy rates, using the same methods to those described
above for baseline diagnosis.
We compared the distributions of age, gender, baseline MMSE, and TIV between the subset
of subjects for which an SNT measure was available and those subjects for which an SNT
measure was not available. In the subset of subjects for which an SNT measure was available
(98 controls, 143 MCI and 62 AD), and separately by subject group, we compared the mean
and SD of measures using MAPS with those from the SNT method. Specifically, we calculated
the mean of the paired differences between the measurements of baseline volume using MAPS
compared to SNT, and calculated 95% CIs assuming normality of these paired differences.
Pitman's method was used to calculate 95% confidence intervals for the ratio of SDs between
the two methods.
We estimated sample sizes required for a hypothetical clinical trial in AD (or MCI) subjects,
using either our methods or the SNT method to calculate atrophy rate. The sample sizes were
calculated using the following formula: sample size = (u + v)2 × (2σ2)/(Δμ)2, where u = 0.841
to provide 80% power and v = 1.96 to test at the 5% significance level, Δμ is the change in the
annualised percentage atrophy between the treatment groups and σ is the SD of rates of atrophy
in the treatment and placebo groups (assuming SD is the same in the treatment and placebo
groups) (Fox et al., 2000). In addition, sample sizes were reported with or without controlling
for normal aging:
• Based on AD (or MCI) atrophy rates alone: sample sizes were calculated to detect a
25% reduction in atrophy rates in AD subjects (Schuff et al., 2009). This implied a
100% effective treatment would reduce atrophy to zero.
• Controlling for normal aging: this was assumed that the difference in atrophy rates
between age-matched controls and AD (or MCI) subjects represents the maximum
possible treatment effect. A 25% reduction in disease progression was thus considered
to be equal to 25% of this difference rather than 25% of the atrophy rates in AD
subjects (Fox et al., 2000).
Confidence intervals for the ratio of sample sizes using the two methods were found using bias-
corrected and accelerated (BCa) bootstrap CIs (100,000 bootstrap samples), using STATA's
bootstrap command (Efron and Tibshirani, 1993). This procedure created 100,000 samples by
sampling subjects (and their data) from the original dataset (with replacement). Since the
distribution of the ratio of estimated sample sizes was non-normal, we report whether p<0.05
on the basis of whether the BCa bootstrap CI for the ratio includes the null value of 1.
We used Pearson's correlation coefficient to estimate the correlations between baseline volume
(and atrophy rates), measured either with our methods or SNT, and two cognitive test scores
likely to be associated with hippocampal function: Auditory Verbal Learning Test score
(AVLT) (Rey, 1964) and Logical Memory I scale of the Wechsler Memory scale (Wechsler,
1981) at baseline. For the AVLT we used the total score of trials I-V. We also estimated the
correlation between hippocampal atrophy rates and the annualised change in AVLT score,
using the baseline and 12-month results. Confidence intervals for the correlation estimates were
found using the STATA corrci command. For differences in correlations between the methods
we used bootstrapping (100,000 bootstrap samples) to estimate the standard error, and found
Wald-type confidence intervals and p-values, assuming normality.
We also compared the MAPS indirect atrophy rates with the MAPS-HBSI rates, using the same
statistical analyses as for the comparison with SNT rates.
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Results
Method optimisation using a manually-segmented subset of 15 subjects
Table 5 and Figure 3 report the mean (SD) JI for each stage in our baseline left hippocampal
region accuracy assessment. We found that the most accurate regions (with a mean JI of 0.83)
were generated using non-linear FFD registration, thresholding and combining the top 8
matches using STAPLE with Markov random field smoothing of interaction strength parameter
0.2. Table 6 shows the means (SD) of the manual and automated hippocampal volumes. The
mean (SD) of differences in the manual and automated hippocampal volumes by baseline
diagnostic group was -56 (126) mm3 (automated > manual) for controls, 57 (78) mm3
(automated < manual) for MCI, and 81 (125) mm3 (automated < manual) for AD subjects.
Overall, the mean (SD) of differences in the manual and automated hippocampal volumes was
27 mm3 (120 mm3) (or 1.2% of mean volume) with manual > automated. The largest outlier
in terms of difference compared with manual measures is shown in Figure 4. This difference
in volume can be largely attributed to the automated region including more of the tail of the
hippocampus and more of the medial aspect than was included in the manual segmentations.
Table 7 shows the mean (SD) rates of atrophy for MAPS-HBSI, manualHBSI and manual
methods. The SD of the difference between manualHBSI and manual rates was 3.33 % /year
for controls, 1.65 % /year for MCI, and 1.01 % /year for AD subjects. The analogous statistics
for the difference between MAPS-HBSI and manual rates was 3.10% /year for controls, 1.50% /
year for MCI, and 1.62 % /year for AD subjects.
The estimated intra-rater ICC (95% CI) of the expert segmentor S1 for the manually segmented
baseline hippocampal volumes was 0.993 (0.980 to 0.998), suggesting very high reliability for
a population in which there are equal numbers of controls, MCI subjects, and AD subjects. For
the repeat volumes the estimated intra-rater ICC was 0.997 (0.992 to 0.999). The mean (SD)
JI between the two different manual segmentations by the same segmentor S1 was 0.91 (0.02)
for AD, 0.92 (0.01) for MCI, 0.92 (0.02) for controls and 0.92 (0.02) for all three groups. The
estimated intra-rater ICC of change in volumes using manual methods was 0.761 (0.444 to
0.910), and for volumes found using manualHBSI was 0.985 (0.957 to 0.995).
The estimated inter-rater ICC (95% CI) between the expert segmentors S1 and S2 for the
manually-segmented baseline hippocampal volumes was 0.953 (0.616 to 0.988), suggesting
high reliability for a population in which there are equal numbers of controls, MCI subjects,
and AD subjects. The mean (SD) JI between the different manual segmentations delineated by
the expert segmentors S1 and S2 was 0.86 (0.03) for AD, 0.88 (0.02) for MCI, 0.87 (0.02) for
controls and 0.87 (0.03) for all three groups. The estimated inter-rater ICC of change in volumes
using manual methods was 0.762 (0.438 to 0.912), and for volumes found using manualHBSI
was 0.953 (0.786 to 0.986).
Furthermore, we found that the mean (SD) JIs between the automated left hippocampal regions
and manually regions delineated by the expert segmentor S2 in the baseline images to be 0.81
(0.03).
Method validation using a manually-segmented subset of 30 subjects
The mean (SD) JIs of the left hippocampus in the baseline images were 0.80 (0.03) for controls,
0.81 (0.03) for MCI, 0.79 (0.0.05) for AD and 0.80 (0.04) across the 3 groups. Table 8 shows
the means (SD) of the of the manual and automated hippocampal volumes. The mean (SD) of
differences in the manual and automated hippocampal volumes by baseline diagnostic group
were 37 (168) mm3 for controls, 82 (93) mm3 for MCI, and 182 (133) mm3 for AD subjects
with automated volumes lower than manual volumes in all the 3 groups. Overall, the mean
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(SD) of differences in the manual and automated hippocampal volumes was 101 mm3 (144
mm3) (or 4.4% of mean volume) with manual > automated.
Analysis of the full dataset
Visual assessment—No large segmentation errors were found in the automated baseline
hippocampal regions. The most common errors were: a) inclusion of extra hippocampal tissue
in the temporal lobe (either white or grey matter) or b) exclusion of some hippocampal tissue
probably due to noisy images and thresholds being too extreme for that specific image (Figure
5). No manual editing was taken to correct these segmentation errors.
Comparison between controls, MCI and AD—Table 9 shows the mean (SD) unadjusted
total (left + right) hippocampal volumes and atrophy rates in the full dataset, together with
adjusted mean differences between groups defined by baseline diagnosis. These are graphically
depicted in Figures 6a (volumes) and 6b (rates) using box plots. We have visually assessed the
baseline and registered repeat images of the outliers with negative atrophy rates in Figure 6(b),
and found that two of them had slightly larger hippocampi in the repeat images and one had
motion artifacts. After adjustment for age, gender and TIV, the estimated mean volume (95%
CI) in the MCI group was 802mm3 (673 to 932, p<0.001) lower than in the control group,
while the adjusted mean in the AD group was 437mm3 (294 to 579, p<0.001) lower than the
MCI group. Adjusting for age and gender, the mean atrophy rate in the MCI group was 1.66
percentage points (1.25 to 2.07, p<0.001) greater than in the control group, while the adjusted
mean rate in the AD group was 1.68 percentage points (1.23 to 2.13, p<0.001) higher than in
the MCI group. The volumes and atrophy rates in the full dataset for the left or right
hippocampus can be found in the Table SP1 in the supplementary data.
Comparison between MCI subgroups—Mean (SD) unadjusted total (left+right)
hippocampal volumes and atrophy rates, together with the adjusted mean differences are shown
in Table 10 for the MCI subgroups. The corresponding box plots are Figures 7a (volumes) and
7b (rates). The adjusted (for age, gender and TIV) mean volume in reverters (95% CI) was
328mm3 (193 lower to 850 higher, p=0.217) and 737mm3 (210 to 1265, p=0.006) higher than
in the stable and converter groups respectively. The adjusted mean volume was 409mm3 (244
to 574, p<0.001) lower in converters compared to stable MCI subjects. Adjusting for age and
gender, the mean atrophy rate in reverters was 0.43 percentage points (-1.24 to 2.10, p=0.61)
lower than stable subjects and 1.84 percentage points (0.15 to 3.53, p=0.03) lower than
converters, while the adjusted mean rate was 1.41 percentage points (0.89 to 1.94, p<0.001)
higher in converters compared to stable subjects. The volumes and atrophy rates of the MCI
subgroups for the left or right hippocampus can be found in the Table SP2 in the supplementary
data.
Comparison between MAPS and SNT—We found no evidence of differences between
the subset of subjects having an SNT measure and the full subset in the distributions of age,
gender, baseline MMSE, and TIV. Table 11 shows the results comparing MAPS with SNT.
The means and SDs of the baseline volumes using MAPS were larger than SNT in all three
groups. There was no evidence that the mean indirect atrophy rate obtained using MAPS differs
from SNT in controls (p=0.26), but in MCI subjects the mean rate (95% CI) using SNT was
0.95 percentage point (0.03 to 1.87, p=0.02) lower than using MAPS, and in AD subjects the
mean rate using SNT was 1.55 percentage points (0.30 to 2.81, p=0.01) higher than using
MAPS. The SDs of the indirect atrophy rates using MAPS were smaller than SNT in all three
groups. For an AD trial powered on hippocampal indirect atrophy rates, the estimated sample
size (95% CI) using MAPS was 12% (36% lower to 90% higher, p>0.05) higher than SNT
when using atrophy rates from AD subjects alone, and the estimated sample size (95% CI)
using MAPS was 71% (42% to 88%, p<0.05) lower than SNT when using atrophy rates from
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MCI subjects alone. In MCI subjects, there was no evidence of correlation between baseline
hippocampal volume and logical memory score, measured either with MAPS (correlation (95%
CI) 0.14 (-0.02 to 0.30), p=0.09), or SNT (0.15 (-0.02 to 0.30), p=0.08), whereas in AD subjects,
there was evidence of positive correlation: 0.38 (0.14 to 0.57, p=0.003) (MAPS), 0.27 (0.03
to 0.49, p=0.03) SNT. In MCI subjects baseline volume was positively correlated with AVLT
score, using both MAPS (0.24 (0.08 to 0.39, p=0.004)) and SNT (0.17 (0.00 to 0.32, p=0.05)),
whereas in AD subjects there was no evidence of correlation. In MCI and AD subjects there
was no evidence of correlation between change in AVLT score and indirect atrophy rate,
measured either using MAPS or SNT.
Comparison between MAPS indirect and direct atrophy rates—Table 12 shows the
results comparing the indirect and direct methods of calculating hippocampal atrophy rates
(MAPS indirect atrophy rate and MAPS-HBSI respectively). There was no evidence that the
MAPS indirect atrophy rate differs from MAPS-HBSI in controls (p=0.13) and AD (p=0.49),
but in MCI subjects the mean MAPS indirect atrophy rate (95% CI) was 0.88 percentage point
(0.38 to 1.37, p<0.001) higher than using MAPS-HBSI. The SDs of the MAPS indirect atrophy
rate were larger than MAPS-HBSI in all three groups. For an AD trial powered on hippocampal
atrophy rates, the estimated sample size (95% CI) using MAPS indirect atrophy rate was 151%
(43% to 466%, p<0.05) higher than MAPS-HBSI when using atrophy rates from AD subjects
alone, and the estimated sample size (95% CI) using MAPS indirect atrophy rate was 50% (9%
to 121%, p<0.05) higher than MAPS-HBSI when using atrophy rates from MCI subjects alone.
In MCI subjects, MAPS-HBSI was negatively correlated with change in AVLT score (-0.22
(-0.38 to -0.06, p=0.008)), but there was no evidence of correlation with MAPS indirect atrophy
rate (-0.15 (-0.31 to 0.02, p=0.08)). In AD subjects there was no evidence of correlation between
change in AVLT score and either MAPS indirect atrophy rate or MAPS-HBSI.
Discussion
Based on a training sample of 15 subjects, we found that the best method for generating a
baseline hippocampal volume with our template library utilised non-linear registration (FFD)
together with intensity thresholding and combining the best matched eight segmentations using
STAPLE to which a Markov random field filter of 0.2 weighting was applied. This generated
volumes whose means and SDs were similar to those produced using manual segmentation,
with the largest difference being in the AD group with automated volumes on average being
lower than manual by 81 mm3 which corresponds to about 4% of the manual AD hippocampal
volume. Overall, the mean difference between our automated volumes and the manual
measurements was 27mm3 or just over 1% of the mean of all volumes. The automated regions
also agreed well (average JI = 0.81) with the manual regions delineated by a second expert
segmentor S2 who did not generate the manual regions in the template library. Using an HBSI
measure on these regions, we were able to produce a rate of atrophy similar to manual atrophy
rates, with the largest difference in means being in the AD group (5.4% manual vs. 6.5%
automated) and the overall mean difference in rates being just under 0.5% /year.
We found that the accuracy of MAPS on unseen data was very high, having achieved a mean
(SD) JI of 0.80 (0.04) when comparing the automated baseline hippocampal regions with
manual regions delineated by the expert segmentor S1 from a set of 30 subjects (10 AD, 10
MCI and 10 controls). The SD of the automated volumes was similar to the manual volumes
in all three groups. The means of automated volumes were smaller than manual volumes in all
three groups, with the largest difference being in the AD group, with automated volumes on
average being lower than manual by 182 mm3 which corresponds to about 10% of the manual
AD hippocampal volume. Overall, the mean (SD) of differences in the manual and automated
hippocampal volumes was 101 mm3 (144 mm3) (or 4.4% of mean volume) with manual >
automated.
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Application of MAPS and MAPS-HBSI to a large dataset showed the expected pattern of
hippocampal volumes (AD<MCI<controls) and atrophy rates (AD>MCI>controls). Further to
this, we found differences across MCI subgroups based on follow-up diagnosis determined up
to 36 months from baseline, with hippocampal volumes statistically significantly lower in those
subjects who progressed to a diagnosis of dementia at some point in the study compared to
those who remained stable or “reverted” to normal. Atrophy rates from MAPS-HBSI also
showed the expected pattern (MCI reverters < MCI stable < MCI converters), with converters
having a hippocampal atrophy rate that was statistically significantly higher than the other
groups and twice as high as the reverters. Although MCI reverters had higher mean volumes
and lower rates than the MCI stable group these differences did not reach statistical
significance, which is likely due to the small size of the reverter group (n=8).
The comparison of our volumes and indirect atrophy rates with those calculated using SNT
(previously published by Schuff et al. (2009) and treated as the gold standard in the work of
Wolz et al. (2010) and Lötjönen, J. et al. (2010)) revealed that there was a marked difference
in volumes, with MAPS having larger volumes than SNT. The difference in absolute volume
is not surprising given that the conventions of anatomical boundaries of the hippocampus differ
slightly between MAPS and SNT (Konrad et al., 2009), e.g. the alveus was included in our
hippocampal regions while it was not included in regions from SNT. The mean indirect atrophy
rate using MAPS was 0.95 percentage point higher than the mean using SNT in the MCI group
and 1.55 percentage points lower than the mean using SNT in the AD group; however the
MAPS indirect atrophy rates had lower SDs in all three groups. The estimated sample sizes
calculated based on MCI atrophy rates using MAPS was 285, which was 71% smaller than
using SNT (981).
Our final investigation of a comparison of MAPS indirect atrophy rate and MAPS-HBSI
showed that the mean MAPS-HBSI was 0.88 percentage point lower than MAPS indirect
atrophy rate in the MCI group. More importantly, the MAPS-HBSI has markedly lower SDs
in all three groups. Possible reasons for the lower SD in rates include the use of a registration-
based method to detect boundary shift of the hippocampus (HBSI) compared with segmentation
of the hippocampus at the two time-points, as has been previously demonstrated in whole brain
analysis (Frost et al., 2004). We have also shown previously that the use of HBSI with a manual
baseline region results in lower SDs of rates in control groups compared with rates generated
from our “gold standard” manual segmentation of baseline and repeat scans (Barnes et al.,
2004; Barnes et al., 2007). Consequently, the estimated sample size calculated based on AD
subjects alone using MAPS-HBSI was 68, which was 60% smaller than using MAPS indirect
atrophy rates. There was evidence of correlation between MAPS-HBSI and 1-year change in
AVLT score in MCI subjects, whereas no evidence of correlations was found between the 1-
year change in AVLT score and MAPS (or SNT) indirect atrophy rates.
Our technical findings relate well to those of other research groups. We found non-linear
registration to perform better than linear registration as this has been previously shown (Woods
et al., 1998b). A combination of labels has also been shown to be useful (Rohlfing et al.,
2004; Warfield et al., 2004) so our finding of overall improvement by including those best
matches was expected. Overall, the different methods of combinations of labels (vote rule,
SBA and STAPLE) produced similarly good results. It is interesting that the results of vote
rule and STAPLE were more similar than those of SBA. STAPLE had slightly better accuracy
than vote rule, which is consistent with a previous publication (Rohlfing et al., 2004). SBA
had slightly lower accuracy than vote rule. This was consistent with previous results showing
that the vote rule had slightly better accuracy when combining more than five segmentations
(see Figure 7a of (Rohlfing and Maurer, Jr., 2007)).
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The optimal number of segmentations for vote rule, SBA and STAPLE were 29, 29 and 8.
Figure 3 shows that segmentation accuracy increases first and approaches a plateau when more
segmentations are combined. A similar plateau effect in the range of 20 – 30 segmentations
was reported by Aljabar et al. (2009) and Collins et al. (2009) when fusing hippocampal
segmentations using the vote rule. It should also be noted that the less accurate (i.e. lower rank)
segmentations may introduce bias into the combined segmentation in all three methods if the
segmentation errors are not randomly distributed. Aljabar et al. (2009) showed a gradual
decrease in accuracy for hippocampal segmentation when more than about 30 ranked atlases
are combined.
Overall, our technique is most similar to that reported by Aljabar et al. (Aljabar et al., 2009).
It differs in the following ways: (1) Aljabar et al. used vote rule to fuse the segmentations,
whereas we used STAPLE with MRF to combine the segmentations. Furthermore, Table 5
shows that STAPLE with MRF performed slightly better than vote rule when used to fuse the
segmentations from our technique; (2) Aljabar et al. ranked the atlases after nonrigidly
registering all the images to the Montreal Neurological Institute (MNI) BrainWeb single
subject simulated T1-weighted MR image, whereas we ranked the atlases after affinely
registering all the images to a single control subject in the template library. Note that Klein et
al. (2008) mentioned the need to initialise the STAPLE algorithm using a probabilistic
segmentation; in the STAPLE implementation given to us by Warfield, this is performed
internally by averaging the input segmentations to provide a global prior.
We have obtained one of the best accuracies reported to-date for automated hippocampal
segmentation when compared with gold standard manual segmentations from a set of 30
randomly chosen subjects (10 AD, 10 MCI and 10 controls) from ADNI. Expressing our JI (of
0.80 from the independent test data) as a Dice score5 equates to 0.89, with the previous highest
Dice scores (N = number of hippocampi in the study) being 0.81(N=100) (Pohl et al., 2007),
0.83 (N=550) (Aljabar et al., 2009), 0.83 (N=60) (Heckemann et al., 2006), 0.86 (N=54)
(Barnes et al., 2008a), 0.86 (N=40) (Morra et al., 2008), 0.86 (N=14) (Fischl et al., 2002), 0.85
(N=30) (Powell et al., 2008), 0.86 (N=40) (van der Lijn et al., 2008), 0.87 (N=30) (Chupin et
al., 2008), 0.88 (N=5) (Gousias et al., 2008) (from a cohort of 2 year old children), 0.85 (N=364)
(Wolz et al., 2010), 0.89 (N=120) (Lötjönen et al., 2010) and 0.89 (N=160) (Collins and
Pruessner, 2009). Note that our inter- and intra-rater JI values correspond to Dice scores of
0.93 and 0.96 respectively. Comparing these to the results from using our automatic method
with different training and test data (0.89) or with the same training data segmented by a
different rater (0.90) or the same rater (0.91), suggests that the method has not been over-
trained, and that there is potential to improve it further, ideally to approach the upper bounds
of inter- or intra-rater agreement.
A large number of studies have shown AD subjects to have lower hippocampal volumes than
controls with MCI subjects having intermediate volumes (AD<MCI<control) (Chupin et al.,
2009a; Henneman et al., 2009; Schuff et al., 2009; Shi et al., 2009). MCI converters have also
been shown to have a lower baseline hippocampal volume compared with non-converters or
stable MCI subjects (Chupin et al., 2009a; Devanand et al., 2007; Jack et al., 2000).
Hippocampal atrophy rates using automated baseline regions and HBSI of 4.4% per year for
AD (mean age = 75) and 1.1% per year for controls (mean age = 76) are similar to those reported
in the literature. A recent meta-analysis of studies prior to ADNI estimated rates to be
approximately 4.7% per year in AD subjects (mean age = 73) and controls 1.4% per year in
healthy controls (mean age = 78) (Barnes et al., 2009). Mean hippocampal atrophy rates in
ADNI have been reported to be 0.8% per year in controls (mean age = 76) and 4.4% per year
5Dice score (D) is related to the Jaccard index (J) by the equation D = 2J/(1+J).
Leung et al. Page 13
Neuroimage. Author manuscript; available in PMC 2011 July 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
in AD (mean age = 76) (Schuff et al., 2009). MCI atrophy rates have been shown to be between
those of AD and controls, with those progressing to a diagnosis of dementia having higher
rates than those remaining stable: median rates being 4.3% vs. 3.0% per year (mean age = 71
in MCI) (Henneman et al., 2009), 3.3% vs 1.8% per year (mean age = 77 in converters and 76
in stable subjects) (Jack et al., 2004).
The strengths of this study include the large and multi-site nature of data collection (though
training and testing subsets were relatively small) and the availability of follow-up on all
subjects enabling assessment of clinical change from baseline. A notable difference between
the outcomes in ADNI and previous studies relates to MCI conversion to AD. One recent meta-
analysis showed that in studies adhering to the Mayo clinic definition, allowing for dementia
type, the conversion rate from MCI to AD was 8.1% /year (95% CI = 6.3–10.0%) (Mitchell
and Shiri-Feshki, 2009). However, the higher rate of conversion in ADNI (∼16% /year) is
likely to due to the stringent criteria used to recruit subjects with MCI meaning they were likely
to be further down the clinical spectrum (i.e. closer to an AD diagnosis) compared with other
studies (Petersen et al., 2009).
We acknowledge a number of limitations to this study. We only performed inter-subject
registration using ratio image uniformity as the cost function rather than evaluating several
possible cost functions. Also, we used the cross-correlation to choose the best-matched images
from the template library rather than evaluating other image similarity measures, since cross-
correlation has been shown to be a good measure for the hippocampus (Aljabar et al., 2009).
Although there is longitudinal follow-up on all subjects there is no pathological confirmation
of disease which would provide diagnostic certainty. However, this is the setting in which
clinical trials must be conducted. Not only did hippocampal atrophy rates differ between AD
and the other groups, but MCI subjects who progressed clinically also had higher rates than
those who did not.
In general, the use of a template library in a multi-atlas method depends on a number of factors,
such as the quality of template images (e.g. signal-to-noise ratio and contrast-to-noise ratio),
anatomical differences between the subjects in the template library and target group, and the
manual segmentation protocol. Although the template library used in this study was from a
different cohort and included a spectrum of hippocampal volumes (both AD and controls) it
did not contain subjects with MCI. However, we saw no evidence that the MCI subjects were
more poorly segmented than the control or AD groups, as they had similar JIs compared with
control and AD groups. This would be expected given the overlap in hippocampal volumes
and morphology across the control-MCI-AD spectrum. Finally, we did not assess whether our
algorithm differed in ability to segment hippocampi or detect change over time according to
imaging site or field strength. However, one previous study reported no evidence of differing
variability across sites (Schuff et al., 2009) and our estimation of HBSI parameters was
performed on a subject by subject basis which allows for some differences across the scanning
sites.
In addition to this, the number of MCI reverters in this study was low at only 8 subjects, which
was small when compared to the number of MCI stable and converters. The MCI reverters
were possibly subjects with small test-retest fluctuations in performance or genuine changes
in cognitive ability. However, they did meet criteria for MCI at baseline and after this time did
not. One would hypothesise that these subjects would have larger hippocampal volumes and
lower rates and with MAPS and MAPS-HBSI we find this was so (albeit differences were not
significant when reverters and stable MCI subjects were compared).
We conclude that MAPS has a high level of accuracy for segmentation of the hippocampus
and is robust to multi-site data. Our automatically obtained regions can be used to measure
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hippocampal volume change over time using boundary shift measures (MAPS-HBSI). These
methods show expected patterns of volume difference AD<MCI<control, and atrophy rate
AD>MCI>control, and show differences in volume and rate in MCI groups according to
clinical follow-up with MCI converters< MCI stable< MCI reverters for volumes, and MCI
converters> MCI stable> MCI reverters for atrophy rates. MAPS and MAPS-HBSI may be
useful in large-scale multi-centre trials to assess both baseline characteristics and disease
progression.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Appendix
Template library creation
The subjects in the template library included 36 subjects with clinically probable AD and 19
controls who had a mean age of approximately 70 years. In brief, all segmentations were
performed using MIDAS software which allows segmentation and viewing of 3D images in
coronal, axial and sagittal planes (Freeborough et al., 1997). Whole brain segmentations were
performed in native space. Hippocampal segmentations were performed using manual
delineation on images rigidly registered (Woods et al., 1998a) to the MNI 305 template
(Mazziotta et al., 1995).
The anatomy in our hippocampal segmentation protocol included dentate gyrus, the
hippocampus proper, the subiculum and the alveus. Measurements were taken from every
coronal slice from the posterior to anterior boundaries using a standard neuroanatomical atlas
(Duvernoy, 1998). The posterior limit of the hippocampus was defined as the coronal slice
where the longest length of the crus of the fornix was seen (Watson et al., 1992). The
hippocampus was bounded superiorly, medially and laterally by cerebrospinal fluid (CSF) and
inferiorly by the white matter subjacent to the subiculum. The head of the hippocampus was
delineated from the amygdala by inclusion of the alveus, which was best seen as a band of high
signal intensity on the sagittal sections. Intensity thresholds restricting hippocampal voxels to
lie within 70 to 110% of mean brain intensity were used to improve consistency by excluding
white matter and CSF voxels.
A library of images was generated for the hippocampus by choosing a 76-year-old male control
subject with MMSE 30/30 (not included in the 19 mentioned above) whose hippocampal
volume was close to the mean hippocampal volume of the whole group. To adjust for the
difference in head position and size, all images were registered using 12 degrees of freedom
(dof) brain-to-brain assessing the cost function (ratio image uniformity) over the segmented
brain regions (Woods et al., 1998a). The hippocampi were then rigidly aligned using only the
single subject control hippocampus regions to assess the cost function. This local rigid
registration was used in order to improve overlap of hippocampal areas. Without distorting the
size and shape of the hippocampus, hippocampal regions for each subject were transformed
using the registration parameters of these steps and dilated by two voxels to provide an area
over which similarity between images could be measured. Note that the dilated regions were
only used for the template selection step.
BSI double intensity window approach
The BSI double intensity window approach was previously described (Hobbs et al., 2009). A
double intensity window was included for the HBSI calculation in order to capture boundary
shift at both the hippocampus–CSF border, and the hippocampus–WM border. The optimal
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intensity window parameters were chosen using an automatic intensity window selection
method. In order to capture most of the tissue-type change between the hippocampus and CSF
(or hippocampus and WM), it was desirable to ignore changes within the same tissue type, and
to maximize changes between different tissue types. Therefore, the lower intensity window for
capturing CSF and hippocampus change was chosen to be (ICSF mean + ICSF std, Ihippo mean −
Ihippo std), and the higher intensity window for capturing hippocampus and WM change was
chosen to be (Ihippo mean + Ihippo std, IWM mean − IWM std) where ICSF mean, ICSF std,
Ihippo mean, Ihippo std, IWM mean and IWM std were the mean and standard deviation of CSF,
hippocampus and WM intensities. Ihippo mean and Ihippo std were estimated over the baseline
hippocampal region, and ICSF mean, ICSF std, IWM mean and IWM std were estimated using a k-
means clustering method over a dilated (by three voxels) hippocampal region.
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Figure 1.
These examples illustrate the wide range of morphological variation in hippocampi from
subjects in the Alzheimer's Disease Neuroimaging Initiative database
(http://www.loni.ucla.edu/ADNI/). (A) A large hippocampal cyst and lack of temporal horn
and (B) malrotation of the hippocampus (tall and narrow). Atrophy causing changes from (C)
normal hippocampus to (D) MCI hippocampus (considerable atrophy) and (E) AD
hippocampus (marked atrophy).
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Figure 2.
Flow chart showing how the best methods and parameters for the automated hippocampal
segmentation are selected.
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Figure 3.
Average Jaccard index of the left hippocampal regions from the baseline images of 15 randomly
selected subjects for vote rule, STAPLE and SBA used to assess the optimal number of
templates to combine in each method. Error bars denote standard errors.
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Figure 4.
The largest outlier of the automated hippocampal segmentation in the subset of 15 subjects in
terms of difference compared with manual measures. This difference in volume can be largely
attributed to the automated region including more of the tail of the hippocampus (lower panel)
and more of the medial aspect of body and tail (upper panels) than was included in the manual
segmentations.
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Figure 5.
Automated hippocampal segmentation errors. (A) Thresholding excluding hippocampal tissue,
(B) extra-hippocampal tissue included (white and grey matter of the temporal lobe) and (C)
exclusion of lateral hippocampal grey matter due to large hippocampal cyst and lack of
temporal horn.
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Figure 6.
Group comparisons using baseline diagnosis (control (n=200), MCI (n=335), AD (n=147)) in
box plots*. (a) Unadjusted total (left+right) hippocampal volumes; (b) Unadjusted atrophy
rates from automated MAPS-HBSI.
*The horizontal line in the box represents the median value, and the box represents the
interquartile range (IQR). The whiskers represent the upper and lower adjacent values, which
are the highest value not greater than 75th percentile + 1.5 times IQR and the lowest value not
less than 25th percentile - 1.5 times IQR. Values outside the whiskers are marked as dots.
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Figure 7.
MCI subgroup comparisons (reverters (n=8), stable (n=204), converters (n=123)) in box plots.
(a) Unadjusted total (left+right) hippocampal volumes; (b) Unadjusted atrophy rates from
automated MAPS-HBSI.
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Table 1
Subject demographics in subset of 15 randomly selected subjects used to establish optimal methods and
parameters. Mean (SD) unless specified otherwise.
Control (n=5) MCI (n=5) AD (n=5)
Age, years 82.7 (4.3) 76.6 (7.1) 75.6 (7.2)
Gender male (%) 2 (40%) 1 (20%) 3 (60%)
Scanning interval, days 380.8 (20.5) 379.8 (17.4) 385.4 (12.2)
MMSE, /30 29.8 (0.4) 27.4 (1.7) 23.2 (1.8)
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Table 2
Subject demographics in subset of 30 randomly selected subjects used for method validation. Mean (SD) unless
specified otherwise.
Control (n=10) MCI (n=10) AD (n=10)
Age, years 78.6 (5.4) 75.3 (8.8) 77.2 (6.8)
Gender
male (%)
6 (60%) 7 (70%) 7 (70%)
MMSE, /30 29.5 (0.7) 27.4 (1.8) 27.0 (2.7)
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Table 3
Subject demographics of the full dataset. Mean (SD) unless specified otherwise.
Control (n=200) MCI (n=335) AD (n=147)
Age, years 76.0 (5.1) 74.9 (7.2) 75.3 (7.3)
Gender male (%) 106 (53%) 213 (64%) 78 (53%)
Scanning interval, days 396.3 (25.8) 394.0 (24.5) 392.6 (23.3)
MMSE, /30 29.1 (1.0) 27.0 (1.8) 23.4 (1.9)
Mean years of clinical follow-up 2.2 (0.6) 1.9 (0.7) 1.8 (0.4)
TIV, ml 1538 (142) 1563 (150) 1536 (168)
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Table 4
Subject demographics of the MCI subgroups. Mean (SD) unless specified otherwise.
MCI reverters
(n=8)
MCI stable
(n=204)
MCI converters
(n=123)
Age, years 70.7 (8.9) 75.3 (7.1) 74.5 (7.2)
Gender male (%) 5 (63%) 133 (65%) 75 (61%)
Scanning interval, days 396.3 (46.0) 396.3 (24.3) 390.1 (22.6)
MMSE, /30 28.0 (1.3) 27.3 (1.8) 26.6 (1.7)
Mean years of clinical follow-up 1.8 (0.5) 1.8 (0.7) 2.1 (0.6)
TIV, ml 1584 (144) 1567 (149) 1554 (154)
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Table 5
Mean (SD) Jaccard index for each stage in the accuracy assessment, separated by groups (control, MCI and AD).
Only the Jaccard indices in all three groups (in the “total” column) were used to choose the optimal methods and
parameters. Mean (SD) JI of MRF parameters are shown to 3 decimal points to distinguish fine-grained effects.
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Table 6
Mean (SD) of the volumes (in mm3) in the left hippocampus in the baseline images of the subset of 15 subjects
used to assess optimal methods and parameters.
Control (n=5) MCI (n=5) AD (n=5)
Manual 2525 (529) 2228 (342) 1900 (299)
Automated 2581 (625) 2172 (400) 1820 (217)
manual vs automated
mean of difference (95% CI) -56 (-212 to 100)
p=0.37
57 (-40 to 154)
p=0.18
81 (-74 to 236)
=0.22
SD of differences 126 78 125
SD ratio (95% CI) 0.85 (0.66 to 1.09)
p=0.13
0.85 (0.66 to 1.10)
p=0.15
1.38 (0.74 to 2.57)
p=0.22
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Table 7
Mean (SD) annualised percentage rates of atrophy in the left hippocampus in the baseline images of the subset
of 15 subjects used to assess optimal methods and parameters.
Control (n=5) MCI (n=5) AD (n=5)
manual 1.53 (2.27) 4.73 (2.02) 5.44 (1.90)
manualHBSI 1.28 (4.19) 4.89 (2.81) 6.97 (1.40)
MAPS-HBSI 1.49 (3.87) 5.18 (2.80) 6.48 (1.06)
manualHBSI vs manual
difference in means
(95% CI)
-0.26 (-4.36 to 3.85),
p=0.87
0.16 (-1.89 to 2.2)
p=0.84
1.53 (0.27 to 2.79)
p=0.03
SD of the difference 3.33 1.65 1.01
SD ratio (95% CI) 1.85 (0.58 to 5.91)
p=0.25
1.39 (0.55 to 3.51)
p=0.39
0.76 (0.31 to 1.72)
p=0.38
MAPS-HBSI vs manual
difference in means
(95% CI)
-0.04 (-3.90 to 3.81)
p=0.98
0.46 (-1.41 to 2.32)
p=0.53
1.05 (-0.97 to 3.06)
p=0.22
SD of the difference 3.10 1.50 1.62
SD ratio (95% CI) 1.71 (0.52 to 5.55)
p=0.31
1.38 (0.59 to 3.24)
p=0.35
0.56 (0.16 to 1.91)
p=0.30
MAPS-HBSI vs manualHBSI
difference in means (95% CI) 0.21 (-0.28 to 0.70)
p=0.30
0.30 (-0.61 to 1.20)
p=0.41
-0.48 (-1.94 to 0.97)
p=0.41
SD of the difference 0.40 0.73 1.17
SD ratio (95% CI) 0.92 (0.83 to 1.03)
p=0.10
0.99 (0.63 to 1.57)
p=0.97
0.76 (0.23 to 2.51)
p=0.59
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Table 8
Mean (SD) of the volumes (in mm3) in the left hippocampus in the baseline images of the subset of 30 subjects
for method validation.
Control (n=10) MCI (n=10) AD (n=10)
Manual 2563 (358) 2331 (410) 1994 (478)
Automated 2526 (304) 2249 (371) 1813 (444)
manual vs automated
mean of difference (95% CI) 37 (-83 to 157)
p=0.25
82 (16 to 149)
p=0.01
182 (87 to 277)
p=0.001
SD of differences 168 93 133
SD ratio (95% CI) 1.18 (0.81 to 1.71)
p=0.35
1.10 (0.93 to 1.31)
p=0.23
1.08 (0.86 to 1.34)
p=0.48
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Table 11
Comparison between our results and those reported by Schuff et al. (2009) obtained from the ADNI website.
Three subjects were excluded from the indirect atrophy rate comparison due to missing SNT volumes at 12-
month follow-up (2 MCI subjects (031_S_0568 and 002_S_0954) and 1 AD subject (141_S_0852)). Three more
subjects were excluded from the correlation analysis because: the baseline AVLT score of 1 AD subject
(099_S_0372) was -1 in Trial V, the 12-month repeat AVLT scores of 1 AD subject (073_S_0565) were all -1
in Trials I-V and the 12-month repeat AVLT scores of 1 MCI subject (067_S_0607) were -1 in Trials IV and V.
MAPS SNT MAPS vs SNT
Mean (SD) baseline total (left+right)
hippocampal volume, mm3
Differences in mean (95%
CI)
SD ratio (95% CI)
Controls (n=98) 5080 (718) 4260 (623) 821 (742 to 900), p<0.001 1.15 (1.03 to 1.30),
p=0.01
MCI (n=143) 4393 (841) 3670 (705) 723 (662 to 785), p<0.001 1.19 (1.11 to 1.28),
p<0.001
AD (n=62) 3946 (921) 3300 (770) 648 (556 to 740), p<0.001 1.27 (1.16 to 1.39),
p<0.001
Mean (SD) indirect atrophy rate, % Differences in mean (95%
CI)
SD ratio (95% CI)
Controls (n=98) 1.40 (3.11) 1.04 (5.41) 0.37 (-0.74 to 1.47),
p=0.26
0.58 (0.47 to 0.70),
p<0.001
MCI (n=141) 3.68 (3.92) 2.73 (5.40) 0.95 (0.03 to 1.87), p=0.02 0.73 (0.62 to 0.85),
p<0.001
AD (n=61) 4.57 (3.76) 6.12 (4.77) -1.55 (-2.81 to -0.30),
p=0.01
0.79 (0.62 to 1.00),
p=0.05
Sample size (95% CI) Sample size ratio (95% CI)
AD rate alone 170 (99 to 486) 152 (93 to 364) 1.12 (0.64 to 1.90), p>0.05
Controlling for aging 354 (169 to 1415) 221 (114 to 643) 1.60 (0.69 to 3.83), p>0.05
Sample size (95% CI) Sample size ratio (95% CI)
MCI rate alone 285 (193 to 470) 981 (522 to 2501) 0.29 (0.12 to 0.58), p<0.05
Controlling for aging 742 (367 to 2143) 2545 (710 to 63884) 0.29 (0.01 to 1.20), p>0.05
Correlation between baseline volume
and logical memory score (95% CI)
Differences in correlation (95% CI)
MCI (n = 143) 0.14 (-0.02 to 0.30)
p=0.09
0.15 (-0.02 to 0.30)
p=0.08
0.00 (-0.07 to 0.06), p=0.90
AD (n = 62) 0.38 (0.14 to 0.57)
p=0.003
0.27 (0.03 to 0.49)
p=0.03
0.10 (-0.01 to 0.21), p=0.07
Correlation between baseline volume
and AVLT (95% CI)
Differences in correlation (95% CI)
MCI (n = 143) 0.24 (0.08 to 0.39)
p=0.004
0.17 (0.00 to 0.32)
p=0.05
0.07 (-0.01 to 0.15), p=0.08
AD (n = 61) 0.12 (-0.14 to 0.36)
p=0.36
0.05 (-0.20 to 0.30)
p=0.70
0.07 (-0.04 to 0.19), p=0.24
Correlation between atrophy rate and
change in AVLT (95% CI)
Differences in correlation (95% CI)
MCI (n=140) -0.15 (-0.31 to 0.02)
p=0.08
-0.02 (-0.19 to 0.14)
p=0.78
-0.13 (-0.35 to 0.09), p=0.26
AD (n = 59) 0.13 (-0.13 to 0.37) 0.05 (-0.21 to 0.30) 0.08 (-0.22 to 0.38), p=0.60
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MAPS SNT MAPS vs SNT
p=0.33 p=0.71
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Table 12
Comparison between MAPS indirect atrophy rate and MAPS-HBSI. Three subjects were excluded from the
indirect atrophy rate comparison due to missing SNT volumes at 12-month follow-up (2 MCI subjects
(031_S_0568 and 002_S_0954) and 1 AD subject (141_S_0852)). Three subjects were excluded from the
correlation analysis because: the baseline AVLT score of 1 AD subject (099_S_0372) was -1 in Trial V, the 12-
month repeat AVLT scores of 1 AD subject (073_S_0565) were all -1 in Trials I-V and the 12-month repeat
AVLT scores of 1 MCI subject (067_S_0607) were -1 in Trials IV and V.
MAPS indirect atrophy
rate
MAPS-HBSI MAPS indirect atrophy rate vs MAPS-HBSI
Mean (SD) atrophy rate, % Differences in mean
(95% CI)
SD ratio (95% CI)
Controls (n=98) 1.40 (3.11) 1.15 (2.02) 0.25 (-0.19 to 0.69),
p=0.13
1.54 (1.33 to 1.78),
p<0.001
MCI (n=141) 3.68 (3.92) 2.80 (2.43) 0.88 (0.38 to 1.37),
p<0.001
1.61 (1.42 to 1.83),
p<0.001
AD (n=61) 4.57 (3.76) 4.57 (2.38) -0.01 (-0.83 to 0.81),
p=0.49
1.58 (1.27 to 1.97),
p<0.001
Sample size (95% CI) Sample size ratio (95% CI)
AD rate alone 170 (99 to 488) 68 (48 to 99) 2.51 (1.43 to 5.66), p<0.05
Controlling for aging 354 (169 to 1419) 121 (77 to 206) 2.92 (1.45 to 8.64), p<0.05
Sample size (95% CI) Sample size ratio (95% CI)
MCI rate alone 285 (193 to 471) 189 (139 to 289) 1.50 (1.09 to 2.21), p<0.05
Controlling for aging 742 (367 to 2147) 545 (296 to 1331) 1.36 (0.73 to 2.80), p>0.05
Correlation between atrophy rate
and change in AVLT (95% CI)
Differences in correlation (95% CI)
MCI (n=140) -0.15 (-0.31 to 0.02)
p=0.08
-0.22 (-0.38 to -0.06)
p=0.008
0.07 (-0.03 to 0.18 to 0.03), p=0.18
AD (n = 59) 0.13 (-0.13 to 0.37)
p=0.33
0.04 (-0.22 to 0.20)
p=0.77
0.09 (-0.23 to 0.41), p=0.58
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